Study details
Enrolling now
Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
Mayo Clinic
NCT IDNCT05739162ClinicalTrials.gov data as of Apr 2026
Target enrollment
12
Study length
about 3.4 years
Ages
22–69
Locations
1 site in MN
What this study is about
Researchers are testing if Endoscopic Sleeve Gastroplasty (ESG) can help obese people with ulcerative colitis lose weight. The trial will last 1229 days and involve a device-based treatment along with lifestyle changes.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Lifestyle Intervention
- 2.Use Apollo Endoscopic Suture System
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Number of subjects with serious adverse events, Percent total body weight loss
Secondary: Change gastrointestinal symptom rating scale (GSRS)
Body systems
Endocrinology, Gastroenterology